Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 6/20 | 0.54 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.54 |
| ▸ | PRKDC | P78527 | 2/20 | 0.45 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CDC25A | P30304 | 1/20 | 0.38 |
| ▸ | CDC25C | P30307 | 1/20 | 0.38 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.37 |
| ▸ | TNKS | O95271 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 1/20 | 0.36 |
| ▸ | HTR7 | P34969 | 1/20 | 0.36 |
| ▸ | HTR6 | P50406 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24217341 | 0.90 | AHR (0.62) | AHRALOX5PRKDCGGPS1PTGES2 | |
| SCHEMBL24097372 | 0.90 | AHR (0.66) | AHRALOX5PRKDCGGPS1CA1 | |
| SCHEMBL22129981 | 0.90 | AHR (0.66) | AHRALOX5PRKDCGGPS1CA1 | |
| SCHEMBL25073586 | 0.88 | AHR (0.54) | AHRALOX5PRKDCGGPS1CA1 | |
| SCHEMBL30203651 | 0.88 | AHR (0.57) | AHRALOX5PRKDCGGPS1CA1 | |
| SCHEMBL22763942 | 0.88 | AHR (0.57) | AHRALOX5PRKDCGGPS1CA1 | |
| SCHEMBL12175683 | 0.86 | ALOX5 (0.69) | AHRALOX5PRKDCGGPS1PTGES2 | |
| SCHEMBL14924577 | 0.86 | ALOX5 (0.69) | AHRALOX5PRKDCGGPS1PTGES2 | |
| SCHEMBL16302998 | 0.86 | ALOX5 (0.69) | AHRALOX5PRKDCGGPS1PTGES2 | |
| SCHEMBL30022593 | 0.86 | ALOX5 (0.69) | AHRALOX5PRKDCGGPS1PTGES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220389018-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2022-12-08 | — | — | US | disclosed |
| US-20210280800-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2021-09-09 | — | — | US | disclosed |
| WO-2020040571-A1 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | 주식회사 엘지화학 | 2020-02-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220389018-A1 | ORGANIC LIGHT EMITTING DEVICE | CYP1A1, ARNT, AOC3 | AHR 4/4885ALOX5 1861/4885PRKDC 4753/4885 |
| US-20210280800-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY1, AOX1, CYBA | AHR 673/4885ALOX5 497/4885PRKDC 4094/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.